BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21970883)

  • 1. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
    Gattolliat CH; Thomas L; Ciafrè SA; Meurice G; Le Teuff G; Job B; Richon C; Combaret V; Dessen P; Valteau-Couanet D; May E; Busson P; Douc-Rasy S; Bénard J
    Br J Cancer; 2011 Oct; 105(9):1352-61. PubMed ID: 21970883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.
    Gattolliat CH; Le Teuff G; Combaret V; Mussard E; Valteau-Couanet D; Busson P; Bénard J; Douc-Rasy S
    Cancer Med; 2014 Aug; 3(4):998-1009. PubMed ID: 24931722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.
    Schulte JH; Schowe B; Mestdagh P; Kaderali L; Kalaghatgi P; Schlierf S; Vermeulen J; Brockmeyer B; Pajtler K; Thor T; de Preter K; Speleman F; Morik K; Eggert A; Vandesompele J; Schramm A
    Int J Cancer; 2010 Nov; 127(10):2374-85. PubMed ID: 20473924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
    Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment.
    Rosswog C; Schmidt R; Oberthuer A; Juraeva D; Brors B; Engesser A; Kahlert Y; Volland R; Bartenhagen C; Simon T; Berthold F; Hero B; Faldum A; Fischer M
    Neoplasia; 2017 Dec; 19(12):982-990. PubMed ID: 29091799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
    González-Vallinas M; Rodríguez-Paredes M; Albrecht M; Sticht C; Stichel D; Gutekunst J; Pitea A; Sass S; Sánchez-Rivera FJ; Lorenzo-Bermejo J; Schmitt J; De La Torre C; Warth A; Theis FJ; Müller NS; Gretz N; Muley T; Meister M; Tschaharganeh DF; Schirmacher P; Matthäus F; Breuhahn K
    Mol Cancer Res; 2018 Mar; 16(3):390-402. PubMed ID: 29330288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
    De Preter K; Mestdagh P; Vermeulen J; Zeka F; Naranjo A; Bray I; Castel V; Chen C; Drozynska E; Eggert A; Hogarty MD; Izycka-Swieszewska E; London WB; Noguera R; Piqueras M; Bryan K; Schowe B; van Sluis P; Molenaar JJ; Schramm A; Schulte JH; Stallings RL; Versteeg R; Laureys G; Van Roy N; Speleman F; Vandesompele J
    Clin Cancer Res; 2011 Dec; 17(24):7684-92. PubMed ID: 22031095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
    Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
    Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival prediction of gastric cancer by a seven-microRNA signature.
    Li X; Zhang Y; Zhang Y; Ding J; Wu K; Fan D
    Gut; 2010 May; 59(5):579-85. PubMed ID: 19951901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
    Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
    Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
    Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
    Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.